Page last updated: 2024-11-01

nimodipine and Pneumothorax, Primary Spontaneous

nimodipine has been researched along with Pneumothorax, Primary Spontaneous in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Easley, CS1
Wartman, FS1
Kopelman, AE1
Louis, TM1

Other Studies

1 other study available for nimodipine and Pneumothorax, Primary Spontaneous

ArticleYear
Effects of nimodipine on brain blood flow following acute brain ischemia in the newborn piglet.
    Developmental pharmacology and therapeutics, 1992, Volume: 18, Issue:1-2

    Topics: Animals; Animals, Newborn; Brain; Brain Ischemia; Hydrogen-Ion Concentration; Nimodipine; Pneumothor

1992